March 19 (Reuters) - Drugmaker Pfizer has sold
its entire stake in Haleon ( HLN ) for about 2.5 billion pounds
($3.24 billion) to institutional investors and the consumer
healthcare firm at 385 pence per share, a bookrunner for the
deal said on Wednesday.
($1 = 0.7708 pounds)
(Reporting by Anandita Mehrotra in Bengaluru; Editing by
Mrigank Dhaniwala)